Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Journal of Environmental Pathology, Toxicology and Oncology
IF: 1.625 5-Year IF: 1.63 SJR: 0.402 SNIP: 0.613 CiteScore™: 2.3

ISSN Print: 0731-8898
ISSN Online: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvPathToxOncol.v22.i4.20
6 pages

Clastogenic Effects of Streptozotocin on Human Colon Cancer Cell Lines with Gene Amplification

Martha Susana Bianchi
Laboratorio de Citogenética y Mutagénesis, Instituto Multidisciplinario de Biologia Celular (IMBICE, CCT-La Plata-CONICET-CICPBA); Miembro de la Carrera del Investigador Cientifico del CONICET, Argentina
Alejandro Daniel Bolzan
Laboratorio de Citogenética y Mutagénesis, Instituto Multidisciplinario de Biologia Celular (IMBICE, CCT-La Plata-CONICET-CICPBA); Miembro de la Carrera del Investigador Cientifico del CONICET, Argentina

ABSTRACT

We investigated the clastogenic effects of the methylating agent streptozotocin (STZ) on two human colon cancer cell lines. COLO320DM and COLO320HSR are cell lines derived from a human neuroendocrine colon carcinoma. STZ produced a dose-dependent increase in the frequency of chromosomal aberrations in both cell lines (p < 0.05) and induced fragmentation and/or pulverization of COLO320DM and COLO320HSR chromosomes. This effect was dose and time dependent. Severe chromosome damage was also found in cells that had progressed beyond the first metaphase, and a higher percentage of metaphases showing pulverized chromosomes were found in cells after the second than after the first division. This seems to indicate that STZ has a persistent and delayed clastogenic effect on COLO320DM and COLO320HSR cells. In addition, STZ produced a marked depression of the mitotic index in both cell lines. These results demonstrate that human colon cancer cell lines COLO320DM and COLO320HSR are highly sensitive to STZ, and suggest that this antibiotic has a good potential as a chemotherapeutic agent for colon cancer.


Articles with similar content:

Antibacterial Medicinal Plants Equiseti Herba and Ononidis Radix Modulate Micronucleus Formation in Human Lymphocytes In Vitro
Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 1
Gordana Joksic, Miroslava Stankovic, Angelina Novak
Cytotoxic Activities of Funalia trogii (Berk.) Bond. Et. Singer ATCC 200800 Bioactive Extract on HeLa Cells and Fibroblast Cells
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Mehmet A. Mazmanci, Ali Unyayar, Murat Demirbilek, Ozlem Cekic, Melisa Turkoglu, Hatice Atacag, Serpil Unyayar, Emrah A. Erkurt, Ayla Celik
Rationale for Targeting of YY1 in Drug-resistant Leukemias
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 1-2
Ferdinando Nicoletti, Franca Stivala, William H. Chappell, Nadia Vella, Stephen L. Abrams, Andrea Marconi, Giovanni Ligresti, James A. McCubrey, Lidia Proietti, Massimo Libra, Linda S. Steelman
Radiofrequency Field-Induced Radiosensitization Is Not Correlated with Induction of Reactive Oxygen Species
Plasma Medicine, Vol.9, 2019, issue 2
Antonio Serafin, John Akudugu, Angela Chinhengo
Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase
Plasma Medicine, Vol.1, 2011, issue 3-4
Masaru Hori, Hiromasa Tanaka, Hiroaki Kajiyama, Kenji Ishikawa, Masaaki Mizuno, Hiroyuki Kano, Kae Nakamura, Fumitaka Kikkawa